Literature DB >> 24388439

Penile rehabilitation with phosphodiesterase type 5 inhibitors after nerve-sparing radical prostatectomy: are we targeting the right patients?

Fabio Castiglione1, Alessandro Nini1, Alberto Briganti2.   

Abstract

The results reported in all trials comparing chronic versus on-demand phosphodiesterase type 5 inhibitor use after bilateral nerve-sparing radical prostatectomy may be affected by improper patient selection. Targeting the right patients is the key to optimizing the efficacy of these drugs.
Copyright © 2013 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24388439     DOI： 10.1016/j.eururo.2013.11.049

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


  5 in total

Review 1.  Psychosocial perspectives on sexual recovery after prostate cancer treatment.

Authors:  Lauren M Walker; Richard J Wassersug; John W Robinson
Journal:  Nat Rev Urol       Date:  2015-03-10       Impact factor: 14.432

2.  Canadian consensus algorithm for erectile rehabilitation following prostate cancer treatment.

Authors:  Dean S Elterman; Anika R Petrella; Lauren M Walker; Brandon Van Asseldonk; Leah Jamnicky; Gerald B Brock; Stacy Elliott; Antonio Finelli; Jerzy B Gajewski; Keith A Jarvi; John Robinson; Janet Ellis; Shaun Shepherd; Hossein Saadat; Andrew Matthew
Journal:  Can Urol Assoc J       Date:  2018-12-03       Impact factor: 1.862

3.  Effects of tadalafil treatment after bilateral nerve-sparing radical prostatectomy: quality of life, psychosocial outcomes, and treatment satisfaction results from a randomized, placebo-controlled phase IV study.

Authors:  Hitendra R Patel; Dapo Ilo; Nimish Shah; Béatrice Cuzin; David Chadwick; Robert Andrianne; Carsten Henneges; Jane Barry; Katja Hell-Momeni; Julia Branicka; Hartwig Büttner
Journal:  BMC Urol       Date:  2015-04-12       Impact factor: 2.264

4.  Effects of tadalafil once daily or on demand versus placebo on time to recovery of erectile function in patients after bilateral nerve-sparing radical prostatectomy.

Authors:  Ignacio Moncada; Fermín R de Bethencourt; Enrique Lledó-García; Javier Romero-Otero; Carmen Turbi; Hartwig Büttner; Carsten Henneges; Juan I Martinez Salamanca
Journal:  World J Urol       Date:  2014-08-26       Impact factor: 4.226

Review 5.  Penile rehabilitation after radical prostatectomy: does it work?

Authors:  Giorgio Gandaglia; Nazareno Suardi; Vito Cucchiara; Marco Bianchi; Shahrokh F Shariat; Morgan Roupret; Andrea Salonia; Francesco Montorsi; Alberto Briganti
Journal:  Transl Androl Urol       Date:  2015-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.